This unique persistent identifier distinguishes this researcher from every other investigator and ensures that their contributions to science are reliably attributed — across institutions, name changes, and international boundaries.
ORCID (Open Researcher and Contributor ID) is the global standard for researcher identification, recognized by journals, funders, and academic institutions worldwide. Connecting publications, grants, and protocols to a single verified identity enables seamless, trustworthy scholarly communication.
Survives institutional changes, name updates, and career transitions
Accepted by thousands of journals, funders, and research systems
Ensures credit for all scholarly and clinical contributions
The protocol record list provides a structured, real-time view of all active, in-progress, and released clinical trials under this researcher's purview. Each record is uniquely identified and mapped to ClinicalTrials.gov where applicable, ensuring full transparency and regulatory alignment.
Intranasal Insulin for Autism Spectrum Disorder — A study investigating insulin delivery in children and young adults aged 4–21 years (IN-INS-AUT). Currently In Progress.
Intra Ovarian Muse Cell Injection for Perimenopause — Symptom relief and ovarian function restoration (MUSE-OVARY). Status: Released. Linked to ClinicalTrials.gov.
Intensive Multimodal Neurorehabilitation — Targeting neuroplasticity in pediatric neurodevelopmental and chromosomal disorders (GEN-HOPE). ClinicalTrials.gov: NCT07493096.
Intranasal AAV9-PrPeB Gene Therapy in Cerebral Palsy (CP) and Hypoxic Ischemic Encephalopathy (HIE) — GEN-HGPE
ClinicalTrials.gov: NCT07264166
Status: Public
Safety and Outcomes of MUSE Stem Cell Therapy in individuals with Traumatic Brain Injury (MUSE-TBI-OBS)
ClinicalTrials.gov: NCT07326059
Status: Public
Both studies represent cutting-edge interventional research in neurological recovery and regenerative medicine.
The MUSE (Multilineage-differentiating Stress Enduring) cell research program spans two active protocols — targeting traumatic brain injury recovery and ovarian function restoration. These studies represent a significant frontier in regenerative and restorative medicine, exploring the body's own pluripotent stem cells as a therapeutic mechanism.
Safety and outcomes monitoring for stem cell therapy post-traumatic brain injury
Intraovarian MUSE cell injection for perimenopause symptom relief and function restoration
Harnessing endogenous pluripotent stem cells to restore tissue function without immune rejection

This observational protocol examines the use of Intravenous Immunoglobulin (IVIG) therapy in patients with severe acute respiratory syndrome caused by SARS-CoV-2. The study follows patients undergoing medical management to evaluate outcomes, safety signals, and immune response patterns.
ClinicalTrials.gov: NCT06992401 | Status: Public
Across all active records, this research portfolio reflects a diverse and rigorous commitment to clinical investigation — spanning gene therapy, stem cell biology, neurorehabilitation, and immunology.
Unique research studies currently tracked and managed
Federally registered trials with public visibility
Neurology, regenerative medicine, women's health, and immunology
Verified persistent researcher identity across all contributions
The record management interface — as visible in the protocol record list — provides administrators and investigators with a structured, searchable view of all registered studies. Key capabilities include:
Each study is assigned a structured institutional identifier for unambiguous tracking across departments and regulatory bodies.
The system surfaces data quality issues — such as incomplete entries or unreleased records — enabling proactive resolution before submission.
Direct mapping between institutional records and federal registry IDs ensures regulatory compliance and public transparency.
Statuses such as In Progress, Released, and Public provide real-time visibility into each protocol's lifecycle stage.

All publications, grants, protocols, and scholarly outputs associated with this investigator are linked through a single, verified ORCID identity. Whether you are a collaborator, journal editor, funding agency, or research administrator, the ORCID profile provides the authoritative source for this researcher's academic record.

A centralized view of active clinical research protocols, ORCID-verified identity, and institutional record tracking — designed for precision, transparency, and research accountability.